Evidence map›Paper›PMID 42259901›Full record

ArticleScientific reports2026

Intelligent Parkinson's disease identification via Residual-Shuffle Network optimized by Improved Dandelion Optimizer.

Xiaowen Wang, Wanyi Huang, Saeid Razmjooy

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xiaowen WangSchool of Education (Shanwei), South China Normal University, Shanwei, 516625, Guangdong, China. wxw321675@163.com.
Wanyi HuangSchool of Education (Shanwei), South China Normal University, Shanwei, 516625, Guangdong, China.
Saeid RazmjooyUniversity of Mohaghegh Ardabili, Ardabil, Iran. Razmjooysaeid@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) presents significant challenges due to its intricate symptoms and often delayed diagnosis. Therefore, early detection is vital for effective management and slowing the disease progression. Recently, machine learning based methods show high performance in this purpose. This research introduces a new machine learning approach that combines Residual-Shuffle Network (ResNet) with an advanced metaheuristic, the Improved Dandelion Optimizer (IDO) by integrating adaptive parameter control and enhanced exploration-exploitation balance, to provide an accessible and precise solution for automated PD detection. The proposed framework addresses previous limitations by effectively adjusting model hyperparameters and network weights without the need for expensive or sophisticated data collection devices. The proposed IDO-ResShuffle framework achieved strong performance on the HandPD dataset, obtaining 97.6% accuracy, 96.9% F1-score, 97.2% sensitivity, and 97.1% specificity. These results demonstrate the effectiveness of jointly optimizing the network architecture and hyperparameters through the Improved Dandelion Optimizer, enabling more reliable identification of Parkinson's disease from handwriting patterns. These enhancements empower healthcare professionals to make informed decisions about patient care sooner and potentially slow down the progression of symptoms. By enhancing accessibility and reliability, this approach can enhance clinical decision-making and support timely intervention in PD management.

Indexed as

Machine LearningParkinson DiseaseAlgorithmsHumansNeural Networks, ComputerAI-based diagnosisHandwriting analysisImproved Dandelion OptimizerMetaheuristicsParkinson’s diseaseResidual-Shuffle NetworkResNet optimization

Identifiers

PMID42259901
PMCPMC13487224

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.